— Know what they know.
Not Investment Advice

RYTM NASDAQ

Rhythm Pharmaceuticals, Inc.
1W: -3.7% 1M: +5.9% 3M: -9.6% YTD: -14.1% 1Y: +41.2% 3Y: +447.6% 5Y: +300.0%
$87.84
-2.35 (-2.61%)
 
Weekly Expected Move ±7.6%
$77 $84 $91 $97 $104
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 58 · $6.0B mcap · 56M float · 1.57% daily turnover · Short 61% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
54.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 4576.6%
Cost Advantage
54
Intangibles
45
Switching Cost
66
Network Effect
82
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. RYTM shows a Weak competitive edge (54.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. ROIC of 4576.6% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$143
Low
$143
Avg Target
$143
High
Based on 1 analyst since May 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 20Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$137.00
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-07 Canaccord Genuity $141 $143 +2 +48.0% $96.61
2026-03-12 Telsey Advisory Initiated $143 +58.9% $90.02
2026-03-03 Jefferies Dennis Ding $80 $125 +45 +39.6% $89.56
2026-02-26 Stifel Nicolaus Paul Matteis $78 $131 +53 +31.6% $99.54
2026-02-18 RBC Capital Lisa Walter Initiated $145 +43.1% $101.30
2026-01-20 H.C. Wainwright $123 $125 +2 +23.0% $101.63
2026-01-20 Wells Fargo Derek Archila Initiated $145 +42.7% $101.63
2025-12-22 H.C. Wainwright Raghuram Selvaraju $110 $123 +13 +9.7% $112.14
2025-12-17 Guggenheim Seamus Fernandez Initiated $140 +24.5% $112.45
2025-12-12 Goldman Sachs $139 $157 +18 +33.6% $117.52
2025-12-12 Canaccord Genuity Whitney Ijem Initiated $141 +20.0% $117.52
2025-12-11 Morgan Stanley $129 $150 +21 +27.6% $117.52
2025-10-17 Goldman Sachs Corinne Johnson $97 $139 +42 +25.0% $111.18
2025-10-16 Morgan Stanley $109 $129 +20 +18.0% $109.35
2025-09-29 H.C. Wainwright Raghuram Selvaraju $70 $110 +40 +10.9% $99.16
2025-09-25 JMP Securities Jonathan Wolleben $64 $142 +78 +43.8% $98.76
2025-08-05 Morgan Stanley $95 $109 +14 +23.1% $88.57
2025-07-10 Oppenheimer Leland Gershell Initiated $110 +23.5% $89.04
2025-07-10 Goldman Sachs Corinne Johnson $66 $97 +31 +8.9% $89.04
2025-07-09 Morgan Stanley Michael Ulz Initiated $95 +6.7% $89.00
2025-03-05 Stifel Nicolaus $25 $78 +53 +47.3% $52.97
2025-03-03 H.C. Wainwright $64 $70 +6 +33.6% $52.40
2025-01-01 Jefferies Dennis Ding Initiated $80 +42.9% $55.98
2024-12-05 Goldman Sachs Corinne Jenkins $59 $66 +7 +10.0% $60.02
2024-11-06 Needham Alan Carr $55 $64 +9 +14.7% $55.78
2024-11-06 Goldman Sachs Corinne Jenkins $35 $59 +24 +5.8% $55.78
2024-09-18 H.C. Wainwright Raghuram Selvaraju Initiated $64 +20.4% $53.17
2024-09-16 JMP Securities Jonathan Wolleben Initiated $64 +18.5% $54.00
2024-07-25 Needham Alan Carr $25 $55 +30 +10.9% $49.61
2022-11-10 Goldman Sachs $28 $35 +7 +41.8% $24.68
2022-08-07 Goldman Sachs Corinne Jenkins $6 $28 +22 +38.3% $20.24
2022-07-12 Goldman Sachs Corinne Jenkins Initiated $6 -6.0% $6.38
2022-06-17 Needham Initiated $25 +541.0% $3.90
2022-06-17 Stifel Nicolaus Dae Gon Ha Initiated $25 +541.0% $3.90

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. RYTM receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-08 C- D+
2026-05-05 D+ C-
2026-03-03 C- D+
2026-02-26 D+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

38 Grade D
Profitability
20
Balance Sheet
39
Earnings Quality
32
Growth
56
Value
32
Momentum
53
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. RYTM scores highest in Safety (100/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
6.53
Safe Zone
Piotroski F-Score
4/9
Beneish M-Score
-2.84
Unlikely Manipulator
Ohlson O-Score
-4.25
Bankruptcy prob: 1.4%
Low Risk
Credit Rating
BBB
Score: 58.5/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.59x
Accruals: -19.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. RYTM scores 6.53, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. RYTM scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. RYTM's score of -2.84 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. RYTM's implied 1.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. RYTM receives an estimated rating of BBB (score: 58.5/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-29.46x
PEG
2.42x
P/S
27.72x
P/B
48.58x
P/FCF
-49.08x
P/OCF
EV/EBITDA
-31.55x
EV/Revenue
26.57x
EV/EBIT
-31.39x
EV/FCF
-47.89x
Earnings Yield
-3.43%
FCF Yield
-2.04%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. RYTM currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.005
NI / EBT
×
Interest Burden
1.097
EBT / EBIT
×
EBIT Margin
-0.846
EBIT / Rev
×
Asset Turnover
0.497
Rev / Assets
×
Equity Multiplier
2.877
Assets / Equity
=
ROE
-133.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. RYTM's ROE of -133.5% is driven by Asset Turnover (0.497), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$87.84
Median 1Y
$80.09
5th Pctile
$27.22
95th Pctile
$235.82
Ann. Volatility
69.7%
Analyst Target
$137.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
David P. Meeker
Chief Executive Officer
$807,692 $8,274,785 $17,544,525
Hunter C. Smith
Chief Financial Officer
$540,477 $2,933,277 $6,228,429
Yann Mazabraud President,
Vice President, Head of International
$557,231 $2,839,739 $6,118,455
Jennifer Lee President,
Vice President, Head of North America
$531,635 $2,649,827 $5,602,816
Alastair Garfield Scientific
ntific Officer
$505,385 $2,082,927 $4,427,024

CEO Pay Ratio

36026:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $17,544,525
Avg Employee Cost (SGA/emp): $487
Employees: 400,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
400,000
+141242.8% YoY
Revenue / Employee
$474
Rev: $189,757,000
Profit / Employee
$-491
NI: $-196,539,000
SGA / Employee
$487
Avg labor cost proxy
R&D / Employee
$418
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -27.0% -27.5% -30.9% -73.7% -78.0% -80.5% -66.1% -65.8% -66.5% -67.7% -85.1% -1.3% -1.2% -1.2% -1.6% -1.0% -1.1% -1.2% -1.3% -1.3% -1.34%
ROA -24.4% -24.9% -27.0% -64.3% -68.0% -70.3% -50.9% -50.7% -51.2% -52.1% -51.6% -76.6% -72.5% -72.4% -71.9% -46.5% -50.5% -53.1% -45.0% -46.4% -46.41%
ROIC 35.8% 38.3% 16.5% 18.3% 18.7% 18.2% 2.1% 2.1% 2.1% 2.2% 1.4% 2.0% 2.0% 2.0% 1.4% 89.7% 92.2% 96.7% 44.5% 45.8% 45.77%
ROCE -85.3% -91.1% -59.4% -65.8% -67.4% -65.5% -51.3% -50.3% -49.8% -50.4% -61.3% -92.7% -86.8% -86.2% -86.8% -53.4% -58.2% -61.6% -46.8% -49.0% -48.98%
Gross Margin 50.0% 78.4% 87.0% 84.6% 95.8% 88.4% 88.3% 87.6% 88.4% 89.3% 86.7% 89.2% 89.9% 88.5% 90.9% 88.8% 88.6% 89.3% 91.6% 88.1% 88.09%
Operating Margin -147.6% -43.0% -28.1% -35.2% -5.0% -9.2% -4.8% -4.6% -2.4% -2.0% -1.7% -5.4% -1.4% -1.3% -98.6% -1.4% -93.4% -1.0% -82.2% -87.1% -87.11%
Net Margin -129.2% -34.2% -23.6% -35.2% -5.0% -9.5% -4.8% -4.5% -2.4% -2.0% -1.7% -5.4% -1.1% -1.3% -1.0% -1.5% -96.1% -1.0% -83.0% -92.6% -92.56%
EBITDA Margin -146.4% -42.6% -27.9% -35.0% -4.9% -8.9% -4.4% -4.2% -2.2% -1.8% -1.5% -5.2% -92.1% -1.2% -89.8% -1.3% -82.7% -93.1% -74.5% -87.1% -87.11%
FCF Margin -411.0% -104.8% -48.0% -37.2% -13.2% -11.1% -7.5% -4.8% -3.6% -2.3% -1.8% -2.0% -1.7% -1.5% -1.2% -82.9% -68.9% -62.6% -61.5% -55.5% -55.47%
OCF Margin -393.3% -100.7% -46.3% -36.0% -12.9% -10.8% -7.3% -4.6% -3.6% -2.3% -1.8% -1.5% -1.3% -1.1% -87.5% -82.9% -68.9% -62.6% -61.0% -55.0% -55.03%
ROE 3Y Avg snapshot only -1.37%
ROE 5Y Avg snapshot only -1.07%
ROA 3Y Avg snapshot only -55.81%
ROIC Economic snapshot only -40.90%
Cash ROA snapshot only -24.84%
NOPAT Margin snapshot only -71.80%
Pretax Margin snapshot only -92.89%
R&D / Revenue snapshot only 79.24%
SGA / Revenue snapshot only 1.01%
SBC / Revenue snapshot only 35.48%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -16.29 -10.65 -7.21 -3.49 -1.19 -6.94 -9.05 -5.60 -5.15 -7.15 -14.74 -9.52 -9.66 -12.39 -13.23 -19.80 -21.98 -33.79 -36.42 -29.17 -29.460
P/S Ratio 3181.56 490.81 159.07 125.57 15.60 75.57 69.36 30.10 21.43 21.40 35.15 28.35 24.61 28.50 26.50 24.41 25.75 37.28 37.72 27.22 27.720
P/B Ratio 5.90 3.94 1.77 2.04 0.74 4.43 6.20 3.83 3.55 5.02 16.03 15.35 14.76 18.89 20.96 20.30 24.46 39.49 51.47 42.51 48.581
P/FCF -7.74 -4.68 -3.31 -3.38 -1.18 -6.83 -9.23 -6.31 -5.88 -9.36 -19.86 -14.37 -14.87 -19.51 -22.41 -29.43 -37.36 -59.55 -61.38 -49.08 -49.075
P/OCF
EV/EBITDA -5.68 -3.18 -1.24 -1.54 0.43 -5.20 -7.51 -3.99 -3.59 -5.82 -14.54 -9.12 -9.32 -12.35 -13.12 -20.66 -23.23 -36.57 -40.29 -31.55 -31.551
EV/Revenue 2632.35 363.88 66.39 62.26 -6.20 58.03 55.34 20.24 13.86 16.05 31.61 25.36 21.91 26.06 24.07 22.09 23.72 35.46 36.97 26.57 26.566
EV/EBIT -5.64 -3.16 -1.23 -1.53 0.43 -5.16 -7.44 -3.95 -3.55 -5.76 -14.39 -9.06 -9.25 -12.26 -13.04 -20.45 -23.00 -36.26 -39.99 -31.39 -31.387
EV/FCF -6.40 -3.47 -1.38 -1.67 0.47 -5.25 -7.36 -4.24 -3.80 -7.02 -17.85 -12.86 -13.24 -17.84 -20.35 -26.64 -34.42 -56.65 -60.16 -47.89 -47.893
Earnings Yield -6.1% -9.4% -13.9% -28.7% -84.0% -14.4% -11.0% -17.8% -19.4% -14.0% -6.8% -10.5% -10.4% -8.1% -7.6% -5.1% -4.5% -3.0% -2.7% -3.4% -3.43%
FCF Yield -12.9% -21.4% -30.2% -29.6% -84.8% -14.6% -10.8% -15.9% -17.0% -10.7% -5.0% -7.0% -6.7% -5.1% -4.5% -3.4% -2.7% -1.7% -1.6% -2.0% -2.04%
PEG Ratio snapshot only 2.418
Price/Tangible Book snapshot only 44.200
EV/Gross Profit snapshot only 29.713
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 10.10 10.10 7.10 7.10 7.10 7.10 8.90 8.90 8.90 8.90 5.58 5.58 5.58 5.58 3.24 3.24 3.24 3.24 4.41 4.41 4.407
Quick Ratio 10.10 10.10 7.10 7.10 7.10 7.10 8.83 8.83 8.83 8.83 5.43 5.43 5.43 5.43 3.08 3.08 3.08 3.08 4.16 4.16 4.164
Debt/Equity 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 1.77 1.77 1.772
Net Debt/Equity -1.02 -1.02 -1.03 -1.03 -1.03 -1.03 -1.25 -1.25 -1.25 -1.25 -1.62 -1.62 -1.62 -1.62 -1.92 -1.92 -1.92 -1.92 -1.02 -1.02 -1.024
Debt/Assets 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.51 0.51 0.512
Debt/EBITDA -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.00 -0.01 -0.01 -0.02 -0.03 -0.02 -0.02 -1.42 -1.35 -1.348
Net Debt/EBITDA 1.18 1.11 1.73 1.56 1.53 1.57 1.90 1.94 1.96 1.94 1.63 1.07 1.15 1.16 1.33 2.16 1.98 1.87 0.82 0.78 0.779
Interest Coverage -4189.93 -85.55 -33.81 -20.85 -14.82 -13.79 -12.09 -16.33 -14.13 -12.49 -11.98 -7.14 -7.35 -7.96 -8.52 -9.30 -9.304
Equity Multiplier 1.12 1.12 1.16 1.16 1.16 1.16 1.45 1.45 1.45 1.45 1.96 1.96 1.96 1.96 2.38 2.38 2.38 2.38 3.46 3.46 3.460
Cash Ratio snapshot only 3.671
Debt Service Coverage snapshot only -9.255
Cash to Debt snapshot only 1.578
FCF to Debt snapshot only -0.489
Defensive Interval snapshot only 386.9 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.00 0.01 0.01 0.02 0.05 0.06 0.07 0.09 0.12 0.17 0.22 0.26 0.28 0.31 0.36 0.38 0.43 0.48 0.43 0.50 0.497
Inventory Turnover 10.79 14.86 19.21 24.16 1.41 2.20 3.42 4.69 1.61 1.85 1.98 2.22 0.98 1.04 1.23 1.35 0.88 1.03 1.034
Receivables Turnover 6.15 9.01 26.16 32.52 6.52 9.27 12.07 17.10 7.34 8.72 9.65 10.67 7.80 8.20 9.36 10.45 8.51 9.74 9.740
Payables Turnover 0.02 0.05 0.11 0.16 0.20 0.25 0.40 0.63 0.98 1.35 1.92 2.21 2.35 2.65 1.55 1.65 1.95 2.15 1.48 1.75 1.751
DSO 0 0 59 41 14 11 56 39 30 21 50 42 38 34 47 45 39 35 43 37 37.5 days
DIO 0 0 34 25 19 15 259 166 107 78 226 197 185 164 374 351 297 270 417 353 353.0 days
DPO 19823 7700 3241 2353 1821 1448 901 578 371 271 190 165 155 138 235 221 187 170 246 208 208.5 days
Cash Conversion Cycle -19823 -7700 -3148 -2288 -1788 -1421 -586 -373 -234 -172 86 74 68 61 185 175 149 135 213 182 182.0 days
Fixed Asset Turnover snapshot only 52.291
Operating Cycle snapshot only 390.5 days
Cash Velocity snapshot only 0.558
Capital Intensity snapshot only 2.216
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 130.9% 42.4% 11.5% 6.5% 6.3% 2.3% 2.7% 2.3% 1.7% 1.3% 81.5% 68.1% 48.9% 53.5% 54.9% 45.8% 58.7% 58.67%
Net Income 55.0% 53.3% 48.0% -2.0% -1.9% -1.9% -1.6% -8.7% -3.7% -2.2% -2.0% -51.7% -42.4% -39.5% -41.1% 38.4% 29.4% 25.7% 24.6% -20.1% -20.15%
EPS 60.5% 59.0% 54.3% -1.9% -1.9% -1.9% -1.3% 3.6% 8.1% 9.2% 3.0% -43.0% -32.7% -31.9% -35.6% 41.3% 32.4% 29.3% 30.5% -11.5% -11.46%
FCF 3.7% -11.9% -23.9% -43.5% -39.7% -31.5% -17.3% 6.5% 10.1% 23.1% 22.9% -13.0% -5.6% -16.0% -12.3% 37.4% 36.1% 33.6% 24.2% -6.1% -6.15%
EBITDA -4.0% -13.3% -24.2% -38.6% -33.5% -21.5% -3.2% 8.8% 11.7% 8.1% 3.4% -49.9% -41.7% -39.0% -41.8% 42.7% 33.3% 28.8% 27.0% -25.0% -24.97%
Op. Income -4.1% -13.6% -24.5% -38.8% -33.9% -22.0% -5.3% 5.0% 6.5% 1.5% -2.9% -51.8% -47.1% -43.4% -44.0% 36.5% 33.2% 29.9% 27.7% -14.3% -14.34%
OCF Growth snapshot only -5.31%
Asset Growth snapshot only 22.67%
Equity Growth snapshot only -15.48%
Debt Growth snapshot only 61.59%
Shares Change snapshot only 7.79%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 12.8% 5.9% 3.4% 2.5% 2.1% 1.3% 1.2% 1.0% 86.3% 86.26%
Revenue 5Y 4.7% 4.74%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 12.8% 7.1% 3.7% 2.6% 2.2% 1.2% 1.2% 99.3% 85.8% 85.77%
Gross Profit 5Y 4.7% 4.75%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 7.2% 7.2% 8.2% 8.2% 8.2% 8.2% 7.4% 7.4% 7.4% 7.4% 21.2% 21.2% 21.2% 21.2% 6.0% 6.0% 6.0% 6.0% 8.0% 8.0% 7.95%
Assets 5Y 20.3% 20.3% 20.3% 20.3% 5.0% 5.0% 5.0% 5.0% 4.9% 4.9% 4.9% 4.9% 20.8% 20.8% 20.80%
Equity 3Y 4.8% 4.8% 4.9% 4.9% 4.9% 4.9% -2.0% -2.0% -2.0% -2.0% 0.6% 0.6% 0.6% 0.6% -16.6% -16.6% -16.6% -16.6% -19.3% -19.3% -19.26%
Book Value 3Y -13.8% -7.8% -7.6% -7.6% -7.6% -8.1% -11.0% -9.9% -10.0% -10.5% -8.7% -6.3% -5.7% -5.8% -22.1% -22.7% -22.9% -22.7% -23.8% -24.0% -24.00%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.60 0.60 0.60 0.61 0.62 0.66 0.49 0.50 0.60 0.58 0.61 0.64 0.71 0.76 0.79 0.82 0.86 0.89 0.91 0.92 0.920
Earnings Stability 0.05 0.00 0.28 0.44 0.38 0.27 0.52 0.61 0.56 0.47 0.42 0.64 0.60 0.53 0.52 0.36 0.48 0.52 0.55 0.40 0.400
Margin Stability 0.95 0.73 0.88 0.94 0.96 0.78 0.90 0.95 0.96 0.98 0.98 0.99 0.99 0.992
Rev. Growth Consistency 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.81 0.50 0.50 0.50 0.50 0.97 0.99 0.99 0.99 0.50 0.83 0.84 0.84 0.85 0.88 0.90 0.90 0.92 0.919
Earnings Smoothness
ROE Trend 0.11 0.14 0.41 -0.16 -0.20 -0.22 -0.16 -0.22 -0.20 -0.20 -0.62 -0.98 -0.87 -0.85 -0.70 0.12 -0.00 -0.06 -0.08 -0.14 -0.138
Gross Margin Trend 0.05 0.15 0.06 0.02 0.02 -0.01 -0.02 0.00 0.00 0.01 0.01 0.01 0.00 0.004
FCF Margin Trend 1722.94 208.47 55.64 26.00 19.00 6.78 5.21 3.46 2.54 1.96 1.25 0.86 0.85 0.846
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 2.01 2.18 2.10 1.00 0.98 0.99 0.96 0.87 0.87 0.76 0.74 0.51 0.50 0.48 0.44 0.67 0.59 0.57 0.59 0.59 0.590
FCF/OCF 1.05 1.04 1.04 1.03 1.03 1.02 1.02 1.03 1.01 1.01 1.01 1.29 1.31 1.32 1.35 1.00 1.00 1.00 1.01 1.01 1.008
FCF/Net Income snapshot only 0.594
CapEx/Revenue 17.7% 4.1% 1.7% 1.2% 32.5% 26.1% 18.1% 12.5% 2.3% 1.5% 1.2% 44.5% 39.3% 35.5% 30.7% 0.0% 0.0% 0.0% 0.5% 0.4% 0.44%
CapEx/Depreciation snapshot only 0.790
Accruals Ratio 0.25 0.29 0.30 -0.00 -0.01 -0.01 -0.02 -0.07 -0.07 -0.13 -0.14 -0.37 -0.37 -0.38 -0.40 -0.15 -0.21 -0.23 -0.19 -0.19 -0.190
Sloan Accruals snapshot only 0.231
Cash Flow Adequacy snapshot only -125.403
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -16.5% -24.6% -32.2% -0.0% -0.0% -9.3% -8.0% -13.0% -14.0% -4.9% -1.9% -2.0% -2.0% -0.2% -1.3% -2.4% -2.0% -4.0% -3.1% -3.4% -3.36%
Total Shareholder Return -16.5% -24.6% -32.2% -0.0% -0.0% -9.3% -8.0% -13.0% -14.0% -4.9% -1.9% -2.0% -2.0% -0.2% -1.3% -2.4% -2.0% -4.0% -3.1% -3.4% -3.36%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.39 1.15 1.00 0.88 0.91 0.96 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.005
Interest Burden (EBT/EBIT) 0.30 0.35 0.41 1.00 1.00 1.01 1.03 1.05 1.07 1.07 1.08 1.06 1.07 1.08 1.08 1.14 1.14 1.13 1.12 1.10 1.097
EBIT Margin -466.62 -115.19 -53.87 -40.77 -14.37 -11.24 -7.44 -5.13 -3.90 -2.79 -2.20 -2.80 -2.37 -2.12 -1.85 -1.08 -1.03 -0.98 -0.92 -0.85 -0.846
Asset Turnover 0.00 0.01 0.01 0.02 0.05 0.06 0.07 0.09 0.12 0.17 0.22 0.26 0.28 0.31 0.36 0.38 0.43 0.48 0.43 0.50 0.497
Equity Multiplier 1.11 1.11 1.15 1.15 1.15 1.15 1.30 1.30 1.30 1.30 1.65 1.65 1.65 1.65 2.17 2.17 2.17 2.17 2.88 2.88 2.877
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.20 $-1.23 $-1.38 $-3.30 $-3.49 $-3.53 $-3.22 $-3.18 $-3.20 $-3.21 $-3.12 $-4.55 $-4.25 $-4.23 $-4.23 $-2.68 $-2.87 $-2.99 $-2.94 $-2.98 $-2.98
Book Value/Share $3.32 $3.31 $5.65 $5.65 $5.64 $5.53 $4.69 $4.66 $4.65 $4.57 $2.87 $2.82 $2.78 $2.77 $2.67 $2.61 $2.58 $2.56 $2.08 $2.05 $1.81
Tangible Book/Share $3.32 $3.31 $5.56 $5.55 $5.55 $5.44 $4.55 $4.52 $4.51 $4.43 $2.75 $2.71 $2.67 $2.66 $2.57 $2.51 $2.49 $2.46 $2.00 $1.97 $1.97
Revenue/Share $0.01 $0.03 $0.06 $0.09 $0.27 $0.32 $0.42 $0.59 $0.77 $1.07 $1.31 $1.53 $1.67 $1.84 $2.11 $2.17 $2.45 $2.71 $2.84 $3.19 $3.19
FCF/Share $-2.53 $-2.79 $-3.01 $-3.41 $-3.52 $-3.58 $-3.16 $-2.83 $-2.81 $-2.45 $-2.32 $-3.02 $-2.76 $-2.69 $-2.50 $-1.80 $-1.69 $-1.70 $-1.74 $-1.77 $-1.77
OCF/Share $-2.42 $-2.68 $-2.90 $-3.30 $-3.43 $-3.50 $-3.08 $-2.75 $-2.79 $-2.43 $-2.30 $-2.34 $-2.11 $-2.03 $-1.85 $-1.80 $-1.69 $-1.70 $-1.73 $-1.76 $-1.76
Cash/Share $3.44 $3.44 $5.87 $5.86 $5.85 $5.74 $5.92 $5.88 $5.86 $5.76 $4.66 $4.59 $4.52 $4.51 $5.20 $5.08 $5.03 $4.98 $5.82 $5.72 $5.01
EBITDA/Share $-2.85 $-3.04 $-3.36 $-3.72 $-3.80 $-3.62 $-3.09 $-3.01 $-2.97 $-2.95 $-2.84 $-4.25 $-3.92 $-3.88 $-3.87 $-2.32 $-2.51 $-2.63 $-2.60 $-2.69 $-2.69
Debt/Share $0.06 $0.06 $0.05 $0.05 $0.05 $0.05 $0.03 $0.03 $0.03 $0.03 $0.02 $0.02 $0.02 $0.02 $0.06 $0.06 $0.06 $0.06 $3.69 $3.63 $3.63
Net Debt/Share $-3.38 $-3.38 $-5.81 $-5.81 $-5.80 $-5.69 $-5.89 $-5.84 $-5.83 $-5.73 $-4.64 $-4.57 $-4.50 $-4.49 $-5.14 $-5.02 $-4.97 $-4.92 $-2.13 $-2.10 $-2.10
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 6.525
Altman Z-Prime snapshot only 11.339
Piotroski F-Score 2 2 3 3 4 4 5 5 5 6 2 3 3 2 4 4 4 5 6 4 4
Beneish M-Score 44.29 35.32 9.68 1.36 3.25 0.21 1.19 -1.65 -3.16 -3.34 -3.37 -3.95 -3.04 -3.11 -3.30 -3.04 -2.84 -2.837
Ohlson O-Score snapshot only -4.255
ROIC (Greenblatt) snapshot only -50.34%
Net-Net WC snapshot only $1.84
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB
Credit Score 74.02 73.71 71.54 74.77 31.58 63.72 65.60 50.00 43.09 61.92 65.72 65.32 65.62 65.55 65.58 65.67 65.68 65.63 59.12 58.46 58.462
Credit Grade snapshot only 9
Credit Trend snapshot only -7.205
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 53
Sector Credit Rank snapshot only 51

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms